Clinical Toxicology (2014), 52, 1032–1283 Copyright © 2014 Informa Healthcare USA, Inc. ISSN: 1556-3650 print / 1556-9519 online DOI: 10.3109/15563650.2014.987397 NPDS REPORT 2013 2013Annual Report of the American Association of Poison Control Centers ’ National Poison Data System (NPDS): 31st Annual Report JAMES B. MOWRY , DANIEL A. SPYKER , LOUIS R. CANTILENA JR, NAYA MCMILLAN , MARSHA FORD For personal use only. Clinical Toxicology Downloaded from informahealthcare.com by 71.16.53.66 on 01/06/15 Address correspondence to: James B. Mowry, PharmD, DABAT, FAACT, American Association of Poison Control Centers, 515 King Street, Suite 510, Alexandria, VA 22314. E-mail:[email protected] 1032 AAPCC 2013 Annual Report of the NPDS 1033 Table of Contents Abstract ................................................................................................................................................................................ 1038 Introduction .......................................................................................................................................................................... 1038 The NPDS Products Database .......................................................................................................................................... 1038 Methods ................................................................................................................................................................................ 1039 Characterization of Participating Poison Centers and Population Served ........................................................................ 1039 Call Management — Specialized Poison Exposure Emergency Providers ........................................................................ 1039 NPDS – Near Real Time Data Capture ............................................................................................................................. 1039 Annual Report Case Inclusion Criteria ............................................................................................................................. 1040 Statistical Methods ............................................................................................................................................................ 1040 NPDS Surveillance ........................................................................................................................................................... 1040 Fatality Case Review and Abstract Selection.................................................................................................................... 1040 Pediatric Fatality Case Review ......................................................................................................................................... 1041 Results .................................................................................................................................................................................. 1041 Information Calls to Poison Centers ................................................................................................................................. 1041 Exposure Calls to Poison Centers ..................................................................................................................................... 1041 Age and Gender Distributions .......................................................................................................................................... 1043 Caller Site and Exposure Site ........................................................................................................................................... 1046 Exposures in Pregnancy .................................................................................................................................................... 1046 Chronicity ......................................................................................................................................................................... 1047 Reason for Exposure ......................................................................................................................................................... 1047 Scenarios ........................................................................................................................................................................ 1047 Reason by Age ............................................................................................................................................................... 1048 Route of Exposure ............................................................................................................................................................ 1048 Clinical Effects .................................................................................................................................................................. 1048 Case Management Site ...................................................................................................................................................... 1049 Medical Outcome .............................................................................................................................................................. 1049 Decontamination Procedures and Specifi c Antidotes ....................................................................................................... 1049 Top Substances in Human Exposures ............................................................................................................................... 1050 Changes Over Time ........................................................................................................................................................... 1051 Distribution of Suicides .................................................................................................................................................... 1052 For personal use only. Plant Exposures ................................................................................................................................................................. 1052 Deaths and Exposure-related Fatalities ............................................................................................................................. 1053 All fatalities — all ages ................................................................................................................................................... 1058 Pediatric fatalities — age Յ 5 years ................................................................................................................................. 1061 Pediatric fatalities — ages 6 – 12 years ............................................................................................................................. 1061 Adolescent fatalities — ages 13 – 19 years ....................................................................................................................... 1061 Pregnancy and Fatalities ................................................................................................................................................ 1062 AAPCC Surveillance Results ........................................................................................................................................... 1062 Discussion ............................................................................................................................................................................ 1062 Clinical Toxicology Downloaded from informahealthcare.com by 71.16.53.66 on 01/06/15 Summary .............................................................................................................................................................................. 1064 Disclaimer ............................................................................................................................................................................ 1064 References ............................................................................................................................................................................ 1064 Appendix APPENDIX A — Acknowledgments .................................................................................................................................... 1257 Poison Centers (PCs) ........................................................................................................................................................ 1257 AAPCC Fatality Review Team ......................................................................................................................................... 1259 AAPCC Micromedex Joint Coding Group ....................................................................................................................... 1260 AAPCC Rapid Coding Team ............................................................................................................................................ 1260 AAPCC Surveillance Team .............................................................................................................................................. 1260 Regional Poison Center (PC) Fatality Awards .................................................................................................................. 1260 APPENDIX B — Data Defi nitions .......................................................................................................................................